Literature DB >> 32550194

The role of using different reference population in the prevalence of low BMD in the thalassemia patients.

Mohammad Reza Mohajeri-Tehrani1, Najmeh Darvishian1, Faezeh Arab1, Sedigheh Salemkar1, Fariba Mohseni1, Bagher Larijani1, Zohreh Hamidi1.   

Abstract

PURPOSE: Prevalence of osteoporosis reported as high as 50% in thalassemia major patients. We compared bone density (BMD) of our patients with results of bone densitometry of participants of a national study, to find if BMD diagnosis is ethnicity sensitive or not.
METHODS: In 177 adult beta thalassemia major patients and 490 normal subjects of 20-39 y/o range, dual-energy X-ray absorptiometry of the spine and femur performed. Normal subjects participated in Iranian Multi-center Osteoporosis Study (IMOS). Mean and standard deviation of normal ones achieved and Z-score of patients re-calculated based on normal Iranians. As BMD of normal participants and patients performed by devices of different brands, analyses done based on calculated standard BMD of all participants.
RESULTS: BMD of patients was significantly lower than normal participants (P value <0.001). Frequency of Z-score ≤-2 found in 52% and 56% of patients in femur and spine regions, respectively. New Z-score of patients according to Iranian normal populations calculated. Frequency of this new Z-score ≤-2 found in 16% and 72% of patients in femur and spine regions, respectively.
CONCLUSIONS: We think in secondary osteoporosis, may be other cut-off points, especially according to BMD of normal population of that geographical region are needed. © Springer Nature Switzerland AG 2019.

Entities:  

Keywords:  DXA; Ethnicity; Normal control; Osteoporosis; Z-score

Year:  2019        PMID: 32550194      PMCID: PMC7270311          DOI: 10.1007/s40200-019-00455-6

Source DB:  PubMed          Journal:  J Diabetes Metab Disord        ISSN: 2251-6581


  30 in total

1.  Bone mineral density in ex-thalassemic pediatric patients.

Authors:  A A Hamidieh; Z Hamidi; L Nedaeifard; R Heshmat; H Haralambous; K Alimoghaddam; B Larijani; A Ghavamzadeh; M-R Mohajeri-Tehrani
Journal:  Hematol Oncol Stem Cell Ther       Date:  2012

Review 2.  Problems of bone analysis in childhood and adolescence.

Authors:  E Schönau
Journal:  Pediatr Nephrol       Date:  1998-06       Impact factor: 3.714

Review 3.  Pediatric bone densitometry.

Authors:  Cornelis van Kuijk
Journal:  Radiol Clin North Am       Date:  2010-05       Impact factor: 2.303

4.  Universal standardization for dual x-ray absorptiometry: patient and phantom cross-calibration results.

Authors:  H K Genant; S Grampp; C C Glüer; K G Faulkner; M Jergas; K Engelke; S Hagiwara; C Van Kuijk
Journal:  J Bone Miner Res       Date:  1994-10       Impact factor: 6.741

5.  Ferrous and ferric differentially deteriorate proliferation and differentiation of osteoblast-like UMR-106 cells.

Authors:  Kornkamon Lertsuwan; Ketsaraporn Nammultriputtar; Supanan Nanthawuttiphan; Supathra Phoaubon; Jomnarong Lertsuwan; Jirawan Thongbunchoo; Kannikar Wongdee; Narattaphol Charoenphandhu
Journal:  Biometals       Date:  2018-07-16       Impact factor: 2.949

Review 6.  Bone recovery after zoledronate therapy in thalassemia-induced osteoporosis: a meta-analysis and systematic review.

Authors:  M Mamtani; H Kulkarni
Journal:  Osteoporos Int       Date:  2009-02-26       Impact factor: 4.507

7.  Insulin sensitivity and beta-cell secretion in thalassaemia major with secondary haemochromatosis: assessment by oral glucose tolerance test.

Authors:  Holger Cario; Reinhard W Holl; Klaus-Michael Debatin; Elisabeth Kohne
Journal:  Eur J Pediatr       Date:  2003-01-15       Impact factor: 3.183

8.  The ability of lumbar spine DXA and phalanx QUS to detect previous fractures in young thalassemic patients with hypogonadism, hypothyroidism, diabetes, and hepatitis-B: A 2-year subgroup analysis from the Taranto Area of Apulia Region.

Authors:  Alberto Argentiero; Cosimo Neglia; Angelo Peluso; Salvatore di Rosa; Antonio Ferrarese; Gianluca Di Tanna; Vincenzo Caiaffa; Marco Benvenuto; Alexandru Cozma; Giovanna Chitano; Nadia Agnello; Daniele Paladini; Nicola Baldi; Alessandro Distante; Prisco Piscitelli
Journal:  J Pediatr Hematol Oncol       Date:  2013-08       Impact factor: 1.289

9.  A cross-sectional study of metabolic and endocrine complications in beta-thalassemia major.

Authors:  Farzad Najafipour; Akbar Aliasgarzadeh; Naser Aghamohamadzadeh; Amir Bahrami; Majid Mobasri; Mitra Niafar; Manouchehr Khoshbaten
Journal:  Ann Saudi Med       Date:  2008 Sep-Oct       Impact factor: 1.526

10.  Pathogenesis of Thalassemia Major-associated Osteoporosis: A Review with Insights from Clinical Experience

Authors:  Agostino Gaudio; Nancy Morabito; Antonino Catalano; Rosario Rapisarda; Anastasia Xourafa; Antonino Lasco
Journal:  J Clin Res Pediatr Endocrinol       Date:  2018-07-11
View more
  1 in total

Review 1.  New Entity-Thalassemic Endocrine Disease: Major Beta-Thalassemia and Endocrine Involvement.

Authors:  Mara Carsote; Cristina Vasiliu; Alexandra Ioana Trandafir; Simona Elena Albu; Mihai-Cristian Dumitrascu; Adelina Popa; Claudia Mehedintu; Razvan-Cosmin Petca; Aida Petca; Florica Sandru
Journal:  Diagnostics (Basel)       Date:  2022-08-09
  1 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.